RecruitingNot ApplicableNCT07514286

Assessment of the Feasibility and Organisational Impact of a Care Pathway Incorporating the MultiSense® Medical Device for Post-operative Home Monitoring of Elderly Patients.


Sponsor

Rhythm Diagnostic Systems

Enrollment

80 participants

Start Date

Jun 3, 2026

Study Type

INTERVENTIONAL

Conditions

Summary

Assessing the clinical and organisational impact of a home-based post-operative monitoring strategy incorporating the MultiSense® device involving 80 patients aged 65 years and over who have undergone major surgery.


Eligibility

Min Age: 65 Years

Inclusion Criteria17

  • Patient aged 65 or over
  • Patient eligible for remote monitoring using the MultiSense® device
  • No psychiatric illness that would prevent them from giving informed consent or receiving optimal treatment and follow-up care
  • Subject affiliated with a health insurance scheme
  • Subject able to read and understand English
  • Subject who has signed an informed consent form
  • Subjects indicated for scheduled surgery
  • Patients indicated for scheduled surgery :
  • Transverse colectomy, by laparotomy
  • Hepatic laparoscopy
  • Laparoscopic or laparoscopic liver surgery (code hlfc or hlfa for procedures)
  • Hysterectomy
  • Adnexectomy
  • Parietal surgery (eventration)
  • Rectal resection
  • Right and left colectomy
  • Stoma closure by direct approach

Exclusion Criteria7

  • Patients already participating in an interventional clinical trial.
  • Patients subject to legal protection measures, guardianship, curatorship, or deprived of their liberty by judicial or administrative decision.
  • Patients hospitalised without consent.
  • Patients unable to complete a questionnaire and without a close relative to assist them in using the solution.
  • Patients admitted to or residing in a health or social care facility (other than for the surgery itself).
  • Persons admitted to or residing in a health or social care institution (other than for the surgery itself);
  • Persons unable to give their free and informed consent.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEMonitoring by MultiSense

The MultiSense device will be placed on the patient's back and will allow physicians to remotely monitor six biological parameters


Locations(4)

Western Cancer Institute of Angers

Angers, France

Bergonié Insititute

Bordeaux, France

Inter-municipal Hospital Centre of Mont-de-marsan

Mont-de-Marsan, France

Western Cancer Institute of Nantes

Nantes, France

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07514286


Related Trials